Position history for AXIOM INVESTORS LLC /DE's holdings in MoonLake Immunotherapeutics
AXIOM INVESTORS LLC /DE holds 25,998 shares of MLTX (MoonLake Immunotherapeutics), worth $342,654 as of 2025-Q4. The position was increased (++3.3% shares). MLTX represents 0.0% of AXIOM INVESTORS LLC /DE's portfolio.
Current Value
$342,654
Current Shares
25,998
Total Value Change
+$162,113
Total Shares Change
+818
Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC
Increased |
| 25,998 |
+3.3% |
| $342,654 |
| 0.0% |
| $13.21 |
24 |
| 2025-Q3 | New | 25,180 | - | $180,541 | 0.0% | $6.24 | 31 |